Patient Square Capital has invested $300 million in its newly formed company Enavate Sciences, a platform focused on growing therapeutic companies. James Boylan will lead Enavate Sciences. MENLO PARK, ...
Healthcare investment firm Patient Square Capital sees a bright future in therapeutics—despite a bear market—cashing in $300 million to form portfolio company Enavate Sciences, which will support and ...
Two of the top health care investors at the investment bank SVB Securities and the private equity giant KKR are starting a new biotech investment firm called Enavate Sciences. Enavate launched Monday ...
Health care private equity investor Patient Square Capital has launched Enavate Sciences, a new portfolio company with an initial capital commitment of $300 million devoted to "enabling innovation ...
MENLO PARK, Calif., July 11, 2022 /PRNewswire/ -- Enavate Sciences, a platform launched by Patient Square Capital to support transformative therapeutic companies, announced today the appointment of ...
(MENAFN- EIN Presswire) EINPresswire/ -- Longshore Capital Partners (“Longshore”) is pleased to announce that it has invested in a leading Microsoft implementation and managed services provider, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results